Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 18 to 75

Effects of Depo-Medrol on Psoas Muscle After Lumbar Spine Surgery

Official title: Effect of Depo-Medrol Application on the Psoas Muscle After Transpsoas LLIF on Post-operative Hip Flexor Weakness, Thigh Pain and Numbness

Run by UConn Health · NCT05929755 · Data updated 2026-11-12

This study tests if giving a corticosteroid called Depo-Medrol to the psoas muscle after lumbar spine surgery can help reduce thigh pain and improve hip strength compared to patients who don’t receive the injection.

More Pain, Postoperative trials

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years to 75 Years
SexAll
Enrollment80 (estimated)
SponsorUConn Health
Academic / other
Locations1 site (Farmington, Connecticut)
StatusRecruiting
StartedMay 12, 2023
Main results expectedAugust 2025
Study endsMay 2027
Registry record updatedJuly 24, 2025
Trial IDNCT05929755 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 18 to 75 undergoing LLIF for lumbar disc degeneration.

Probably not a fit

Patients with significant spinal deformities, chronic steroid use, or certain comorbid conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the impact of administering a corticosteroid, Depo-Medrol, to the psoas muscle following a transpsoas lateral lumbar interbody fusion (LLIF) procedure. It aims to assess differences in postoperative thigh pain, hip flexor weakness, and numbness between patients receiving the injection and those who do not. The study will measure outcomes at three postoperative intervals: 2-3 weeks, 6 weeks, and 12 weeks, using various pain and quality of life scales. Additionally, it will evaluate the effect of Depo-Medrol on fusion rates and consider how patient demographics and comorbidities influence outcomes.

Why it matters

Potential benefit: If successful, this approach could significantly reduce postoperative pain and improve recovery for patients undergoing lumbar spine surgery.

How similar studies have gone: While corticosteroid use in postoperative settings has been explored, this specific application in LLIF is relatively novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients from the practices of Drs. Singh, Mallozzi, Moss
* Transpsoas (PTP or LTP) lateral lumbar interbody fusion (LLIF) 1-3 disc levels with posterior instrumentation (Open or MIS) with or without laminectomy, must include L3-4 and/or L4-5
* Patients who agree to be a part of the study
* Patients with lumbar disc degeneration
* Patients between ages of 18 and 75

Exclusion Criteria:

* Scoliosis \>10°
* Spondylolisthesis \>Grade 1
* Flatback deformity
* Patients with insulin dependent diabetes
* Patients with \>3 levels of fusion
* Alternative interbodies
* Chronic oral steroid users
* Patients with allergy/intolerance to depo-medrol or other steroids
* Patients requiring bilateral transpsoas approaches
* Patients with ipsilateral symptomatic hip pathology
* Revision fusion procedures
* Cases involving trauma, tumor, or infection
* Patient's not capable of providing consent themselves
* Non-fluent English speakers (for consenting reasons)
* Patients who are lost to follow-up before the two year follow up period

Where it's running

  • UConn Health
    Farmington, Connecticut, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.